Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Intraoperative Exparel, a Bupivacaine Liposome Injectable Suspension, for Postoperative Pain Control in Total Knee Arthroplasty: A Prospective, Randomized, Double Blind, Controlled Study

NCT02808728 is registered in ClinicalTrials.gov with DeClaire LaMacchia Orthopaedic Institute as lead sponsor.

NCT NCT02808728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02808728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Intraoperative Exparel, a Bupivacaine Liposome Injectable Suspension, for Postoperative Pain Control in Total Knee Arthroplasty: A Prospective, Randomized, Double Blind, Controlled Study
Lead sponsor
DeClaire LaMacchia Orthopaedic Institute
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2014
Completion date
June 30, 2016
Enrollment
100 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, pain management, total knee arthroplasty